HYCOR Biomedical Relocates HQ to Central Indiana
04/27/2011
"Given Indiana's central location, the exceptional life sciences talent based here, as well as the economic incentives being offered by the state, we believe this is the ideal time for HYCOR to relocate as our business continues to grow," said Richard Aderman, president and CEO of HYCOR.
The Indiana Economic Development Corporation offered HYCOR up to $640,000 in performance-based tax credits based on the company's job creation plans.
HYCOR is currently leasing space in Indianapolis before selecting a permanent central Indiana location.
The company produces urinalysis and allergy and autoimmune testing products used in labs, hospitals, and doctor's offices.
Project Announcements
Swiss-Based Hoffmann-La Roche Limited Expands Mississauga, Ontario, Canada, Operations
12/12/2024
Wrap Technologies Plans Norton, Virginia, Manufacturing-Distribution Operations
12/12/2024
C BLOX Plans Montgomery-Huntsville, Alabama, Data Center Operations
12/12/2024
EaglePicher Technologies Expands Joplin, Missouri, Manufacturing Operations
12/10/2024
France-Based Sartorius Stedim Plans Marlborough, Massachusetts, Bioprocess Operations
12/10/2024
357 Brewers Expands Myrtle Beach, South Carolina, Operations
12/05/2024
Most Read
-
How Automation Is Actually Closing the Labor Gap
Q4 2024
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
The Role of Rail in Industrial Development
Q4 2024
-
Hydrogen Industry in Canada: A Global Leader in the Clean Energy Revolution
Q3 2024
-
Which AI Tools Work for Job Recruiters?
Q3 2024
-
Permitted Power Capacity Foreshadows Health of Regional Economies
Q3 2024
-
Navigating Non-Disclosure Agreements in Site Selection
Q3 2024